Proximal Roux‐en‐Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P‐glycoprotein Substrates
- 10 March 2015
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 35 (4) , 361-369
Abstract
Study Objectives: To evaluate the effect of Roux‐en‐Y gastric bypass surgery (RYGB) on the pharmacokinetics of midazolam (a CYP3A4 substrate) and digoxin (a P‐glycoprotein substrate).Design: Prospective, nonblinded, longitudinal, single‐dose pharmacokinetic study in three phases: presurgery baseline and postoperative assessments at 3 and 12 months.Patients: Twelve obese patients meeting current standards for bariatric surgery.Measurements and Main Results: At each study visit, patients received a single dose of oral digoxin and midazolam at 8 a.m. Blood samples were collected at regular intervals for 24 hours after dosing. Continuous 12‐lead electrocardiogram (EKG), heart rate, blood pressure, and respiratory rate were monitored, and pharmacokinetic parameters from the three visits were compared. The peak plasma concentration (Cmax) of midazolam increased by 66% and 71% at 3‐ and 12‐month post‐RYGB (p=0.017 and p=0.001, respectively), whereas the median time to peak concentration (Tmax) was reduced by 50%. The mean Cmax for 1′‐hydroxymidazolam increased by 87% and 80% at 3 and 12 months (p=0.001 and pmax decreased from 40 minutes at baseline to 30 and 20 minutes at 3 and 12 months, respectively. The mean AUC for digoxin, heart rate, and EKG patterns were similar across the three study phases.Conclusion: Contemporary proximal RYGB increases the rate of drug absorption without significantly changing the overall exposure to midazolam and digoxin. The Cmax of a CYP3A4 substrate with a high extraction ratio was substantially increased after RYGB.Keywords
Funding Information
- ACCP Research Institute Frontiers Research Award
- NIH National Center for Research Resources (UL1 RR025014, KL2 RR025015, TL1 RR025016, M01-RR-00037)
- University of Washington General Clinical Research Center
- University of Washington School of Pharmacy DMTPR
This publication has 32 references indexed in Scilit:
- Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/ObesityInternational Journal of Molecular Sciences, 2013
- Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatinSurgical Endoscopy, 2012
- Gastric Bypass Surgery Is Followed by Lowered Blood Pressure and Increased Diuresis - Long Term Results from the Swedish Obese Subjects (SOS) StudyPLOS ONE, 2012
- Predicting Drug Candidate Victims of Drug-Drug Interactions, using MicrodosingClinical Pharmacokinetics, 2012
- Trends in Use of Bariatric Surgery, 2003−2008Journal of the American College of Surgeons, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- A systematic review of drug absorption following bariatric surgery and its theoretical implicationsObesity Reviews, 2009
- Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot studyClinical Transplantation, 2007
- Protein expression pattern of P–glycoprotein along the gastrointestinal tract of the yucatan micropigJournal of Biochemical and Molecular Toxicology, 2004
- The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man.Circulation, 1977